About Us Locations Disclaimer

Dr. R. deGoma

Home
Prevention 2011
Who Needs Prevention
Benefits of Prevention
Risk Assessment
Advanced Lipid Therapy
Stent vs Medical Therapy
Specialized Center
Performance Data
Employer Mandate
Employee Prevention
Patient Mentoring
Coronary Calcium Score
Women & Heart Disease
NJPreventiveCardiology.com

 

Click here for NJ Preventive Cardiology practice brochure

 

Mentoring Program

The Million Hearts Initiative

For Physicians:

Practical Tips for Clinicians

For Communities:

Heart2Heart Talk

For Employers and Employees: You and Health Reform

     



 

Employees are eligible for evidence-based preventive treatment if they are at risk for heart disease and stroke. The foundation of heart attack and stroke prevention for those at high risk is cholesterol management. Insurance will cover for up to 6 visits a year for cholesterol management. If employees reach recommended treatment goals, they may become eligible for premium discount in 2014. 

Cholesterol problem can be simple or complex. Minimum treatment targets for high risk patients are LDL cholesterol less than 100 mg/dl (less than 70 mg/dl for very high risk patients), LDL particle number less than 1,000, non-HDL cholesterol less than 130 mg/dl, HDL cholesterol over 40 mg/dl for men and over 50 mg/dl for women and triglycerides less than 150 mg/dl. Treatment range from non-drug approach to single drug to combination drug therapy. Some treatment goals can been achieved in two months, some may take two years.

Emil M. deGoma, MD, FACC

Medical Director,

UPenn Preventive Cardiovascular  Program

Health Premium Discount

Lower your risk for heart attack and stroke using evidence-based therapies and become eligible for a substantial premium discount by 2014.
Health Reform 2010
Prevention and Wellness Summary Provisions
Relay Health
Contact Office for Non-Urgent Matters

 

We Support Million Hearts Initiative

 

497,470 Preventable CHD Deaths Annually with Evidence-based Medical Therapy

 

JAMA: 38% of Nonacute Stents Called into Question

 

Optimal Medical Therapy Still Underused in CHD

 

Legacy Effects of Statin Therapy - Reduction in All-Cause Mortality

 

SG2 Expert Talks About Resetting Priorities in Cardiology

 

AHA: Get With The Guidelines - Not Much Improvement

 

AIM-HIGH Trial - Take Home Message

 

    
www.deGomaMD.com
Copyright 2001-2011     Preventing Most Heart Attacks and Strokes since 2001     eMedical Consulting     All rights reserved